CARDONE, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 135
AS - Asia 130
NA - Nord America 85
SA - Sud America 11
Totale 361
Nazione #
RU - Federazione Russa 84
US - Stati Uniti d'America 84
SG - Singapore 49
CN - Cina 35
HK - Hong Kong 21
IE - Irlanda 20
IT - Italia 19
BR - Brasile 9
IN - India 9
DE - Germania 8
KR - Corea 8
JP - Giappone 4
EC - Ecuador 2
NL - Olanda 2
VN - Vietnam 2
AT - Austria 1
AZ - Azerbaigian 1
CA - Canada 1
CZ - Repubblica Ceca 1
KG - Kirghizistan 1
Totale 361
Città #
Moscow 33
Singapore 23
Hong Kong 21
Santa Clara 20
Dublin 18
Hefei 9
Ashburn 8
Chandler 8
Seoul 8
Beijing 6
Dallas 6
Bengaluru 5
New York 5
Aversa 4
Munich 4
Los Angeles 3
Naples 3
Amsterdam 2
Bremen 2
Cambridge 2
Hyderabad 2
Princeton 2
Rome 2
Roxbury 2
Shanghai 2
São Paulo 2
Baku 1
Bishkek 1
Bologna 1
Brno 1
Brooklyn 1
Cascavel 1
Cercola 1
Des Moines 1
El Paso 1
Falkenstein 1
Florence 1
Guangzhou 1
Guayaquil 1
Haikou 1
Hanoi 1
Houston 1
Iporá 1
João Pessoa 1
Mumbai 1
New Delhi 1
Newark 1
Oeiras 1
Pozzuoli 1
Poções 1
Secaucus 1
Seropédica 1
St Petersburg 1
São Bernardo do Campo 1
Taiyuan 1
The Dalles 1
Tokyo 1
Toronto 1
Vienna 1
Totale 235
Nome #
Cetuximab rechallenge plus avelumab in pretreated patients with RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial 93
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 79
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial 76
Pimasertib hydrochloride 71
Panitumumab plus trifluridine/tipiracil as anti‐EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial 53
Totale 372
Categoria #
all - tutte 1.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.501


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 0 0 0 4 3 0 0 2 1 4
2022/202332 3 0 1 1 6 2 0 2 12 0 3 2
2023/202430 3 0 1 0 7 6 3 2 1 0 2 5
2024/2025114 2 3 0 14 18 16 18 14 10 5 3 11
2025/2026182 18 26 25 10 42 61 0 0 0 0 0 0
Totale 372